Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 28, 2025
DMARC MSP Case Study: PowerDMARC Enables ImpactQuill to Launch White-Labeled DMARC Platform
EIN Presswire
·
May 28, 2025
DE, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- PowerDMARC, a global leader in email authentication and domain security solutions, has empowered marketing and SEO consultancy ImpactQuill to launch IQDMARC — a fully white-labeled DMARC monitoring …
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
EIN Presswire
·
May 28, 2025
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the rollout of a new AI-powered assistant LISBON, PORTUGAL, May 28, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically …
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
GlobeNewswire
·
May 28, 2025
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …
IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
May 28, 2025
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …
Nyxoah to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
Nyxoah to Present at the Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgium – May 28, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops …
Nyxoah Participera à la Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
Nyxoah Participera à la Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgique – 28 mai 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale développant …
CVRx to Present at the William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 28, 2025
MINNEAPOLIS, May 28, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular …
Gentherm Announces Participation in Upcoming Second Quarter 2025 Investor Conferences
GlobeNewswire
·
May 28, 2025
NOVI, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor events …
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
GlobeNewswire
·
May 28, 2025
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Goldman Sachs 46th Global …
Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows: Date …
Sanuwave Health Selected for Inclusion in Russell 2000® Index
GlobeNewswire
·
May 28, 2025
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 2025 Russell indexes reconstitution, the Company’s …
LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference
GlobeNewswire
·
May 28, 2025
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs …
CoreMap, Inc. Receives U.S. FDA Investigational Device Exemption (IDE) Approval for INvENI Map-Guided AF Ablation Study
GlobeNewswire
·
May 28, 2025
BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend the INvENI clinical study into the U.S. This study is …
Supernus Announces Paragraph IV ANDA Filings for Qelbree®
GlobeNewswire
·
May 28, 2025
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that …
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs …
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and …
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in …
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
GlobeNewswire
·
May 28, 2025
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash …